Martin Puhr

Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205

Martin Puhr, Julia Hoefer, Georg Schäfer et al. · American Journal Of Pathology · 2012 · 258 citations · Full text

<scp>ZEB</scp> 1‐associated drug resistance in cancer cells is reversed by the class I <scp>HDAC</scp> inhibitor mocetinostat

Simone Meidhof, Simone Brabletz, Waltraut Lehmann et al. · EMBO Molecular Medicine · 2015 · 227 citations · Full text

The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy

Martin Puhr, Julia Hoefer, Andrea Eigentler et al. · Clinical Cancer Research · 2017 · 166 citations · Full text

Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells

Luigi Ippolito, Alberto Marini, Lorenzo Cavallini et al. · Oncotarget · 2016 · 139 citations · Full text

Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo

Lei Gu, Paraskevi Vogiatzi, Martin Puhr et al. · Endocrine Related Cancer · 2010 · 123 citations · Full text